Profile-II is a one-step qualitative screening assay for the detection of cannabinoids (THC), cocaine, opiates, amphetamines and Phencyclidine (PCP) or their metabolites in human urine.
     The device also contains a Lateral Flow Adulterant Strip (LatFlo) which is a one-step qualitative screening assay for the detection of oxidants, nitrites, glutaraldehyde, specific gravity and pH values to evaluate human urine specimens for adulteration prior to Drugs of Abuse urine testing.
     The cut-offs concentrations are: THC 50/ng/mL; cocaine 300 ng/mL; opiates 2000 ng/mL; amphetamine 1,000 ng/mL; Phencyclidine 25 ng/mL.
     Results of clinical trials performed for FDA submission were: accuracy of 98-99%; sensitivity of 95-100%; specificity of 99-100% and reproducibility of 99+%.
     Profile-II provides only a preliminary analytical test result. A more specific alternate chemical method must be used to confirm the analytical result.
MedTox Diagnostics Inc.
www.medtox.com
Keyword: drugs of abuse, test, poc